Gyroscope Therapeutics Holdings Ltimited (VISN)
VISN has a market cap or net worth of $613.82 million. The enterprise value is $618.34 million.
VISN has 29.23 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||n/a|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||n/a|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||715.67|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
|Debt / Equity||8.46|
|Debt / EBITDA||-0.49|
|Debt / FCF||-0.50|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||$5,174|
|Profits Per Employee||-$318,395|
|Effective Tax Rate||0.49%|
Stock Price Statistics
|Total Price Change||n/a|
|50-Day Moving Average||n/a|
|200-Day Moving Average||n/a|
|Average Volume (30 Days)||n/a|
Short Selling Information
|Short % of Shares Out||n/a|
|Short % of Float||n/a|
|Short Ratio (days to cover)||n/a|
In the last 12 months, VISN had revenue of $864,000 and -$53.17 million in losses. Earnings per share was -$1.82.
|Earnings Per Share (EPS)||-$1.82|
The company has $20.92 million in cash and $25.43 million in debt, giving a net cash position of -$4.51 million or -$0.15 per share.
|Cash & Cash Equivalents||20.92M|
|Net Cash Per Share||-$0.15|
|Book Value Per Share||0.10|
In the last 12 months, operating cash flow was -$48.23 million and capital expenditures -$2.83 million, giving a free cash flow of -$51.06 million.
|Operating Cash Flow||-48.23M|
|Free Cash Flow||-51.06M|
|FCF Per Share||-$1.75|
Gross margin is 87.04%, with operating and profit margins of -7,516.67% and -6,154.17%.
Dividends & Yields
VISN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|